14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      What do these scores mean? Presenting patient‐reported outcomes data to patients and clinicians to improve interpretability

      research-article
      , PhD 1 , 2 , 3 , , , PhD 2 , 3 , , MHS 3 , , PhD 1 , 2 , , ScM 3 , , MD, MSc 4 , the PRO Data Presentation Stakeholder Advisory Board
      Cancer
      John Wiley and Sons Inc.
      cancer, clinical practice, interpretation, patient management, patient‐reported outcomes

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BACKGROUND

          Patient‐reported outcomes (PROs) (eg, symptoms, functioning) can inform patient management. However, patients and clinicians often have difficulty interpreting score meaning. The authors tested approaches for presenting PRO data to improve interpretability.

          METHODS

          This mixed‐methods study included an Internet survey of cancer patients/survivors, oncology clinicians, and PRO researchers circulated via snowball sampling, plus individual in‐person interviews. Clinical importance was conveyed using 3 approaches (presented in random order): normal score range shaded green, concerning scores circled in red, and red threshold lines indicating normal versus concerning scores. Versions also tested 2 approaches to score directionality: higher = more (better for function, worse for symptoms) and higher = better for both function and symptoms. Qualitative data from online comments and in‐person interviews supplemented quantitative results on interpretation accuracy, clarity, and the “most useful” format.

          RESULTS

          The survey included 1113 respondents: 627 survivors, 236 clinicians, and 250 researchers, plus 10 patients and 10 clinicians who were purposively sampled interviewees. Interpretation accuracy ranged from 53% to 100%. The formats in which higher = better were interpreted more accurately versus those in which higher = more (odds ratio [OR], 1.30; 95% confidence interval [CI], 1.07‐1.58) and were more likely to be rated “very”/“somewhat” clear (OR, 1.39; 95% CI, 1.13‐1.70) and “very” clear (OR, 1.36; 95% CI, 1.18‐1.58). Red circle formats were interpreted more accurately than green‐shaded formats when the first format presented (OR, 1.29; 95% CI, 1.00‐1.65). Threshold‐line formats were more likely to be rated “very” clear than green‐shaded (OR, 1.43; 95% CI, 1.19‐1.71) and red‐circled (OR, 1.22, 95% CI, 1.02‐1.46) formats. Threshold lines were most often selected as “most useful.”

          CONCLUSIONS

          The current results support presenting PRO data with higher = better directionality and threshold lines indicating normal versus concerning scores. Cancer 2017;123:1848–1859 . © 2017 The Authors. Cancer published byWiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations aremade.

          Abstract

          Patient‐reported outcomes (PROs) (eg, symptoms, well being) can be used for patient management and monitoring. This study informs best practices for displaying PRO results so that patients and clinicians can understand what the scores mean.

          Related collections

          Most cited references17

          • Record: found
          • Abstract: found
          • Article: not found

          The applications of PROs in clinical practice: what are they, do they work, and why?

          Precisely defining the different applications of patient-reported outcome measures (PROs) in clinical practice can be difficult. This is because the intervention is complex and varies amongst different studies in terms of the type of PRO used, how the PRO is fed back, and to whom it is fed back. A theory-driven approach is used to describe six different applications of PROs in clinical practice. The evidence for the impact of these applications on the process and outcomes of care are summarised. Possible explanations for the limited impact of PROs on patient management are then discussed and directions for future research are highlighted. The applications of PROs in clinical practice include screening tools, monitoring tools, as a method of promoting patient-centred care, as a decision aid, as a method of facilitating communication amongst multidisciplinary teams (MDTs), and as a means of monitoring the quality of patient care. Evidence from randomised controlled trials suggests that the use of PROs in clinical practice is valuable in improving the discussion and detection of HRQoL problems but has less of an impact on how clinicians manage patient problems or on subsequent patient outcomes. Many of the reasons for this may lie in the ways in which PROs fit (or do not fit) into the routine ways in which patients and clinicians communicate with each other, how clinicians make decisions, and how healthcare as a whole is organised. Future research needs to identify ways in with PROs can be better incorporated into the routine care of patients by combining qualitative and quantitative methods and adopting appropriate trial designs.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial.

            Patients receiving cancer-related thoracotomy are highly symptomatic in the first weeks after surgery. This study examined whether at-home symptom monitoring plus feedback to clinicians about severe symptoms contributes to more effective postoperative symptom control. We enrolled 100 patients receiving thoracotomy for lung cancer or lung metastasis in a two-arm randomized controlled trial; 79 patients completed the study. After hospital discharge, patients rated symptoms twice weekly for 4 weeks via automated telephone calls. For intervention group patients, an e-mail alert was forwarded to the patient's clinical team for response if any of a subset of symptoms (pain, disturbed sleep, distress, shortness of breath, or constipation) reached a predetermined severity threshold. No alerts were generated for controls. Group differences in symptom threshold events were examined by generalized estimating equation modeling. The intervention group experienced greater reduction in symptom threshold events than did controls (19% v 8%, respectively) and a more rapid decline in symptom threshold events. The difference in average reduction in symptom interference between groups was -0.36 (SE, 0.078; P = .02). Clinicians responded to 84% of e-mail alerts. Both groups reported equally high satisfaction with the automated system and with postoperative symptom control. Frequent symptom monitoring with alerts to clinicians when symptoms became moderate or severe reduced symptom severity during the 4 weeks after thoracic surgery. Methods of automated symptom monitoring and triage may improve symptom control after major cancer surgery. These results should be confirmed in a larger study.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Review of electronic patient-reported outcomes systems used in cancer clinical care.

              The use of electronic patient-reported outcomes (PRO) systems is increasing in cancer clinical care settings. This review comprehensively identifies existing PRO systems and explores how systems differ in the administration of PRO assessments, the integration of information into the clinic workflow and electronic health record (EHR) systems, and the reporting of PRO information.
                Bookmark

                Author and article information

                Contributors
                csnyder@jhu.edu
                Journal
                Cancer
                Cancer
                10.1002/(ISSN)1097-0142
                CNCR
                Cancer
                John Wiley and Sons Inc. (Hoboken )
                0008-543X
                1097-0142
                13 January 2017
                15 May 2017
                : 123
                : 10 ( doiID: 10.1002/cncr.v123.10 )
                : 1848-1859
                Affiliations
                [ 1 ]Johns Hopkins School of Medicine Baltimore Maryland.
                [ 2 ]Johns Hopkins Bloomberg School of Public Health Baltimore Maryland
                [ 3 ]Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland
                [ 4 ]Queens Cancer Research Institute Kingston OntarioCanada
                Author notes
                [*] [* ] Corresponding author: Claire F. Snyder, PhD, Associate Professor of Medicine, 624 N. Broadway, Room 649, Baltimore, MD 21205; Fax: (410) 955‐0470; csnyder@ 123456jhu.edu
                Article
                CNCR30530
                10.1002/cncr.30530
                5419857
                28085201
                a95b29c7-6e40-4640-ac6b-2f97a08646a4
                © 2017 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society.

                This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 08 August 2016
                : 19 October 2016
                : 07 December 2016
                Page count
                Figures: 4, Tables: 3, Pages: 13, Words: 3904
                Funding
                Funded by: Patient‐Centered Outcomes Research Institute (PCORI)
                Award ID: R‐1410‐24,904
                Funded by: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
                Award ID: P30CA006973
                Categories
                Original Article
                Original Articles
                Discipline
                Quality of Life
                Custom metadata
                2.0
                cncr30530
                May 15, 2017
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.0.9 mode:remove_FC converted:17.05.2017

                Oncology & Radiotherapy
                cancer,clinical practice,interpretation,patient management,patient‐reported outcomes

                Comments

                Comment on this article